Avantor reports second quarter 2019 resultsLearn more
Industries we serve
Avantor works with ambitious clients in a broad range of industries, using deep knowledge and a collaborative approach to create and deliver innovative products and solutions across them all.
Opportunities and challenges in cell and gene therapy development
Q&A interview with Ger Brophy, Avantor’s Executive Vice President, Biopharma Production
Avantor serves our global customers with a proven portfolio of trusted, quality brands, as well as products from thousands of other manufacturers.
Processing times can be reduced and yields increased by utilizing new hydrophobic interaction chromatography tools.
A global pharmaceutical company sought new ways to help senior scientists focus more time and attention on innovation and strategic drug project work.
A medical device OEM needed a fast cure silicone adhesive to boost throughout to maximize efficiencies.
News & events
Learn how we support and enable the industries we serve.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the quarter ended June 30, 2019...
Avantor® Announces Pricing of Initial Public Offering and Concurrent Offering of Mandatory Convertible Preferred Stock
Avantor, Inc., announced today that it has priced the initial public offering of 207,000,000 shares of its common stock at a price to the public of $14.00 per share...
Avantor, Inc., announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) and listing of Avantor’s common stock...
Avantor today announced it will highlight its NuSil brand biocompatible silicone adhesives and other technologies at MD&M West 2019, February 5-7 in Anaheim, Calif...